USANA Health Sciences Inc... (USNA)
23.84
0.10 (0.42%)
At close: Apr 21, 2025, 3:59 PM
23.83
-0.06%
After-hours: Apr 21, 2025, 05:48 PM EDT
USANA Health Sciences Revenue Breakdown
| Period Ending | Sep 28, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 |
|---|---|---|---|---|---|---|
| All Other Revenue | 1.75M | 1.65M | 1.48M | 1.43M | 1.41M | 1.48M |
| All Other Revenue Growth | +6.17% | +11.70% | +3.21% | +1.85% | -4.93% | n/a |
| Direct Selling Revenue | 198.47M | 226.15M | 219.6M | 211.93M | 236.79M | 246.88M |
| Direct Selling Revenue Growth | -12.24% | +2.98% | +3.62% | -10.50% | -4.08% | n/a |
Revenue by Geography
| Period Ending | Dec 30, 2023 | Dec 31, 2022 |
|---|---|---|
| Americas And Europe Revenue | 180.57M | 196.69M |
| Americas And Europe Revenue Growth | -8.19% | n/a |
| Asia Pacific Revenue | 740.43M | 801.92M |
| Asia Pacific Revenue Growth | -7.67% | n/a |
| Greater China Revenue | 475.1M | 502.49M |
| Greater China Revenue Growth | -5.45% | n/a |
| North Asia Revenue | 101.45M | 108.95M |
| North Asia Revenue Growth | -6.89% | n/a |
| Southeast Asia Pacific Revenue | 163.89M | 190.48M |
| Southeast Asia Pacific Revenue Growth | -13.96% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Jan 2, 2021 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | Jan 2, 2016 | Oct 3, 2015 | Jul 4, 2015 | Apr 4, 2015 | Jan 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 61.3M | 150.88M | 160.06M | 154.54M | 153.23M | 170.48M | 173M | 158.98M | 164.11M | 185.59M | 188.42M | 183.28M | 182.87M | 226.1M | 206.13M | 198.96M | 196.8M | 171.73M | 181.55M | 179.44M | 177.32M | 178.37M | 192.09M | 200.99M | 199.38M | 200.33M | 199.49M | 191.51M | 183.27M | 180.79M | 179.78M | 174.74M | 173.41M | 175.09M | 164.03M | 157.27M | 154.28M | 154.38M | 151.23M | 157.72M |
| Selling, General, and Administrative Revenue Growth | -59.38% | -5.73% | +3.57% | +0.86% | -10.12% | -1.46% | +8.82% | -3.13% | -11.57% | -1.50% | +2.81% | +0.22% | -19.12% | +9.69% | +3.60% | +1.10% | +14.60% | -5.41% | +1.18% | +1.19% | -0.59% | -7.14% | -4.43% | +0.81% | -0.47% | +0.42% | +4.17% | +4.49% | +1.37% | +0.56% | +2.88% | +0.77% | -0.96% | +6.75% | +4.30% | +1.94% | -0.07% | +2.09% | -4.11% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 11.45M | n/a | n/a | n/a | 11.56M | n/a | n/a | n/a | 11.11M | n/a | n/a | n/a | 10.63M | n/a | n/a | n/a | 10.26M | n/a | n/a | n/a | 10.24M | n/a | n/a | n/a | 8.95M | n/a | n/a | n/a | 8.84M | n/a | n/a | n/a | 6.42M | n/a | n/a | n/a | 5.13M |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a |